Showing results (1561-1570 of 4,229) with videos related to
Sort By:
Pageof 423
Discover Oncology|July 19, 2025
Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesisRichard Maliye, Shari Babu, Anna E Harris, et al.Discover Oncology|July 18, 2025
Associations between circulating metabolites and pca: a bidirectional two-sample Mendelian randomization studyJing Lv, Yonghong DengDiscover Oncology|July 19, 2025
Ten-year outcomes of IMRT with chemotherapy versus IMRT alone for stage II-IVa nasopharyngeal carcinoma: a retrospective studyXiao-Li Wang, Da-Qing Sun, Hui Yang, et al.Discover Oncology|July 18, 2025
Identification of biomarkers for Laryngeal squamous cell carcinoma through Mendelian randomization and integrated bioinformatics analysisPengjian Zhang, Weizhang Chen, Kai Chen, et al.Discover Oncology|July 18, 2025
Systemic strategies for osteosarcoma: advances and future directionsVivek Kumar Morya, Anuja Gajanan Magar, Sin-Hye Park, et al.Discover Oncology|July 18, 2025
Non-coding RNAs and Hippo signaling in non-small cell lung cancer: emerging roles as biomarkers and therapeutic targetsMohammadamin Joulani, Nahal Aghajamal, Masoumeh Nouri, et al.Discover Oncology|July 23, 2025
Mucinous carcinoma of the breast: epidemiological, clinical, and prognostic characteristics; a single-center experienceOmar Hamdy, Mosab Shetiwy, Mahmoud M Saber, et al.Discover Oncology|July 23, 2025
RNF213 governs divergent tumor-immune dynamics across human cancers: a prognostic biomarker for immunotherapy stratificationJinpeng Wen, Zhekuan Lv, Mojiao Lu, et al.Discover Oncology|July 24, 2025
Integrated network toxicology and bioinformatics reveal PFAS-driven prognostic biomarkers and molecular mechanisms in breast cancer: insights from transcriptome analysis and molecular dockingYingqiang Fu, Yiyang Liu, Ziqi SuiDiscover Oncology|July 22, 2025
Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemiaSathyanarayan Balaji, Suvitha Anbarasu, Sudha Ramaiah, et al.Pageof 423